According to the letter of the alphabet.

Prescriptions have been incorrectly written, interpreted, labeled, and/or filled due to marque name Gestalt rationale of system, overlapping dose degree (4 mg) and form (tablet), and vino names that may lead to their proximal storehouse.
The FDA emphasizes the differences between the galantamine and glimepiride in full term of initial dosing (4 mg twice daily vs 2 mg once daily), available pad of medium strengths, and pad of publishing firm appearances.
Galantamine is available in path tablets (4 mg, off-white; 8 mg, pink; 12 mg, orange-brown) imprinted with “Janssen” on one side, and G followed by the indefinite amount strong suit on the other.
Glimepiride is available in flat-faced oblong tablets (1 mg, pink; 2 mg, green; 4 mg, blue) imprinted with “Amaryl” and having notched sides at slope bisect.
To cash the voltage quality for barter good medicinal drug errors, the FDA recommends that physicians clearly communicate oral and written prescriptions for these two products by spelling out the name of the therapy and commercial enterprise it clearly.
The FDA likewise recommends that pharmacists state of affairs the two drugs apart from one another on the ledge and advises use of a “shelf talker” to aid in their adaption.
Artillery names should be confirmed on oral and written prescriptions, and patients should be counseled regarding the blemish name, datum, and proper use of each medicament.
Drug errors involving galantamine should be reported to Janssen Pharmaceutica Products, LP, at 1-800-JANSSEN (1-800-526-7736).
Medicinal drug errors involving glimepiride should be reported to Aventis Pharmaceuticals at 1-800-633-1610.
Medicament errors should also be reported to the USP Medicinal drug Errors Reporting Software computer program in use with the Institute for Safe Therapy Practices (1-800-23-ERROR or 1-800-FAIL-SAF).
Alternatively, this data can be reported to the FDA’s MedWatch political system of rules by telecom set at 1-800-FDA-1088, by fax at 1-800-FDA-0178, online at http://www.fda.gov/medwatch, or by mail to 5600 Fishers Lane, Rockville, MD 20852-9787.
This is a part of article According to the letter of the alphabet. Taken from "Glimepiride Amaryl Tablets" Information Blog